2024-03-28T23:55:36Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_4024F0C5F587
2024-03-23T02:15:56Z
serval:BIB_4024F0C5F587
Delayed immune-related adverse events with anti-PD-1-based immunotherapy in melanoma.
10.1016/j.annonc.2021.03.204
000658413300013
33798657
Owen
C.N.
author
Bai
X.
author
Quah
T.
author
Lo
S.N.
author
Allayous
C.
author
Callaghan
S.
author
Martínez-Vila
C.
author
Wallace
R.
author
Bhave
P.
author
Reijers
ILM
author
Thompson
N.
author
Vanella
V.
author
Gerard
C.L.
author
Aspeslagh
S.
author
Labianca
A.
author
Khattak
A.
author
Mandala
M.
author
Xu
W.
author
Neyns
B.
author
Michielin
O.
author
Blank
C.U.
author
Welsh
S.J.
author
Haydon
A.
author
Sandhu
S.
author
Mangana
J.
author
McQuade
J.L.
author
Ascierto
P.A.
author
Zimmer
L.
author
Johnson
D.B.
author
Arance
A.
author
Lorigan
P.
author
Lebbé
C.
author
Carlino
M.S.
author
Sullivan
R.J.
author
Long
G.V.
author
Menzies
A.M.
author
article
2021-07
Annals of oncology
1569-8041
0923-7534
journal
32
7
917-925
anti-PD1
delayed
immunotherapy
irAE
melanoma
toxicity
Immunotherapy
anti-PD-1
eng
60_published
peer-reviewed
Publication types: Journal Article
Publication Status: ppublish